ALOX15 and asthma: Consistent with these findings, we previously showed that increased 15-LOX-1 in bronchial epithelia and nasal polyp basal epithelial cells of patients with asthma contributes to redox dysregulation, inflammation, and worse clinical outcomes (1, 62).